| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |